73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signaling

by Sichuan International Medical Exchange and Promotion AssociationExpression of CREB3 is decreased in HCC tissues and correlated with better clinical outcome. (A) mRNA expression of CREB3 in HCC tiss
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc
New treatment could increase lung cancer survival

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll
Cancer diagnoses dropped sharply in Alberta during COVID-19 response

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well
Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B
'Bad fat' suppresses killer T cells from attacking cancer

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research
CAR T cell therapy may eliminate tumor cells missed by surgery

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc
Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P
ASCO: low-dose chemo benefits advanced gastroesophageal cancer

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s
New treatment for urinary tract cancer could prevent kidney dialysis, transplant

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health